Larvol Delta - Diakonos-Oncology-Announces-Final-Closing-of-Oversubscribed-114M-Seed-Financing-to-Advance-Its-Highly-Differentiated-Dendritic-Cell-Vaccine-DOC1021-into-a-Phase-2-Clinical-Trial

DOC1021 - Diakonos Research

https://www.businesswire.com/news/home/20240826545283/en/Diakonos-Oncology-Announces-Final-Closing-of-Oversubscribed-11.4M-Seed-Financing-to-Advance-Its-Highly-Differentiated-Dendritic-Cell-Vaccine-DOC1021-into-a-Phase-2-Clinical-Trial

Aug 26, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next